Debate: Albumin administration should be avoided in the critically ill
The benefit of albumin administration in the critically ill patient is unproven. Epidemiological evidence suggests that there is an increase in death among patients with burns, hypoalbuminaemia, and hypotension treated with human albumin solution (HAS). In critical illness, hypoalbuminaemia is a res...
שמור ב:
| הוצא לאור ב: | Crit Care |
|---|---|
| Principais autores: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2000
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137253/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11211856/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cc688 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|